Literature DB >> 11668166

Nephrocalcinosis in preterm babies.

A Narendra1, M P White, H A Rolton, Z I Alloub, G Wilkinson, J H McColl, J Beattie.   

Abstract

OBJECTIVES: To determine prospectively the incidence and cause of nephrocalcinosis in preterm infants. STUDY
DESIGN: Inborn babies of gestation less than 32 weeks or birth weight less than 1500 g were eligible to be entered into a prospective observational study. Two renal ultrasound scans were performed, the first at 1 month postnatal age and the second at term or discharge. Data were collected on gestation, birth weight, sex, race, family history of renal calculi, oliguria on first day, respiratory support (ventilation, steroid, and oxygen dependency), and use of nephrotoxic drugs (gentamicin, vancomycin, and frusemide). Intake of fluid, calcium, and phosphate and plasma urea, creatinine, calcium, and phosphate were recorded for the first 6 weeks of life. Random urinary calcium/creatinine, oxalate/creatinine, and urate/creatinine ratios and tubular absorption of phosphate were measured once at term.
RESULTS: A total of 101 preterm infants were studied. Twenty three (23%) had abnormal ultrasound scans. Sixteen (16%) had nephrocalcinosis. On univariate analysis, gestational age, male sex, duration of ventilation, oxygen dependency, duration and frequency of gentamicin treatment, toxic gentamicin/vancomycin levels, and postnatal dexamethasone were significantly associated with nephrocalcinosis. In addition, babies with nephrocalcinosis had a lower intake of fluid, calcium, and phosphate, longer duration of total parenteral nutrition, and higher urinary oxalate/creatinine and urate/creatinine ratios than infants who did not have the condition. There was also a significant association with plasma urea and creatinine but not with plasma calcium or phosphate or urinary calcium. Multivariate analysis showed that the strongest predictors of nephrocalcinosis were duration of ventilation, toxic gentamicin/vancomycin levels, low fluid intake, and male sex.
CONCLUSION: 16% of babies born at less than 32 weeks gestation developed nephrocalcinosis. The multifactorial origin, in particular, the association with extreme prematurity and severity of respiratory disease, is confirmed. In addition, an association with male sex, frequency and duration of gentamicin use, and high urinary oxalate and urate excretion is shown.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668166      PMCID: PMC1721318          DOI: 10.1136/fn.85.3.f207

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  42 in total

1.  Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits.

Authors:  P T Frame; J P Phair; C Watanakunakorn; T W Bannister
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

2.  Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy.

Authors:  M R Myracle; J P McGahan; B W Goetzman; R D Adelman
Journal:  J Clin Ultrasound       Date:  1986-05       Impact factor: 0.910

Review 3.  Urolithiasis in children: the role of hypercalciuria.

Authors:  F B Stapleton; C P McKay; H N Noe
Journal:  Pediatr Ann       Date:  1987-12       Impact factor: 1.132

4.  Effect of phosphorus intake in total parenteral nutrition infusates in premature neonates.

Authors:  R A Vileisis
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

5.  Renal calcification in preterm infants: pathophysiology and long-term sequelae.

Authors:  F Ezzedeen; R D Adelman; C E Ahlfors
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

6.  Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birthweight infants.

Authors:  T Saarela; A Vaarala; P Lanning; M Koivisto
Journal:  Acta Paediatr       Date:  1999-06       Impact factor: 2.299

7.  Renal calcifications: a complication of long-term furosemide therapy in preterm infants.

Authors:  K G Hufnagle; S N Khan; D Penn; A Cacciarelli; P Williams
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

8.  Renal calcification incidence in very low birth weight infants.

Authors:  J S Jacinto; H D Modanlou; M Crade; A A Strauss; S K Bosu
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

9.  The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

Authors:  W G Robertson; M Peacock
Journal:  Nephron       Date:  1980       Impact factor: 2.847

10.  The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.

Authors:  W M Bennett; C E Plamp; D N Gilbert; R A Parker; G A Porter
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

View more
  18 in total

Review 1.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  Is additional oral phosphate supplementation for preterm infants necessary: an assessment of clinical audit.

Authors:  Stewart Watts; Helen Mactier; June Grant; Eilidh Cameron Nicol; Alexander Balfour Mullen
Journal:  Eur J Pediatr       Date:  2013-05-24       Impact factor: 3.183

3.  Does citrate prevent nephrocalcinosis in preterm neonates?

Authors:  Eveline A Schell-Feith; Aukje Moerdijk; Paul H T van Zwieten; Harmine M Zonderland; Herma C Holscher; Joana Kist-van Holthe; Bert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2006-10-13       Impact factor: 3.714

4.  Renal function and kidney length in preterm infants with nephrocalcinosis: a longitudinal study.

Authors:  Vasileios Giapros; Constantina Tsoni; Anna Challa; Vasileios Cholevas; Maria Argyropoulou; Frederica Papadopoulou; Ekaterini Siomou; Aikaterini Drougia; Styliani Andronikou
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

5.  Neonatal nephrocalcinosis: long term follow up.

Authors:  E Porter; A McKie; T J Beattie; J H McColl; N Aladangady; A Watt; M P White
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05-16       Impact factor: 5.747

Review 6.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 7.  Urolithiasis in infants.

Authors:  Jallouli Mohamed; Mhiri Riadh; Nouri Abdellatif
Journal:  Pediatr Surg Int       Date:  2007-02-08       Impact factor: 1.827

8.  Development of nephrocalcinosis in very low birth weight infants.

Authors:  Guido Hein; Detlef Richter; Friedrich Manz; Dieter Weitzel; Hermann Kalhoff
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

9.  Developmental changes of oxalate excretion in enterally fed preterm infants.

Authors:  S Illsinger; T Lücke; B Vaske; K-H Schmidt; B Bohnhorst; A M Das
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

10.  High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.

Authors:  David J Cranefield; David E Odd; Jane E Harding; Rita L Teele
Journal:  Pediatr Radiol       Date:  2003-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.